Retatrutide's Weight Loss Potential and Associated Risks Under Scrutiny | Retatrutide News

Retatrutide, a GLP-1 agonist from Eli Lilly, shows potential for weight loss but raises safety concerns. Medical experts emphasize the need for a thorou...
Weight Loss · October 11, 2026